Kate Haviland
CIK 1663022 · Chief Executive Officer · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
57
Lifetime Open-Market Net
-$13.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FULC | Director | — | $3.75 | — | $0 | 8 | 2026-07-02 |
| BCAX | Director | — | $27.73 | — | $0 | 3 | 2026-06-10 |
| AVLN | Director | — | $34.56 | — | $0 | 1 | 2026-05-01 |
| Blueprint Medicines Corp (BPMC) Delisted | Chief Executive Officer | 0 | $129.46 | $0 | -$13.58M | 43 | 2025-07-21 |
Recent Filings · Page 3 of 6
57 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-11-07 | Blueprint Medicines Corp (BPMC) Delisted | Buy (P) | +1,100 | $48.4K | EDGAR |
| 2022-06-29 | FULC | Grant (A) | — | $0 | EDGAR |
| 2022-03-08 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −2,767 | -$162.5K | EDGAR |
| 2022-03-03 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +40,000 | $0 | EDGAR |
| 2021-12-15 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$62.2K | EDGAR |
| 2021-09-15 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$63.9K | EDGAR |
| 2021-06-30 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$54.2K | EDGAR |
| 2021-06-11 | FULC | Grant (A) | — | $0 | EDGAR |
| 2021-03-17 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$69.6K | EDGAR |
| 2021-03-05 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −1,952 | -$169.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.